Skip to content

Psilocybin for Depression. Reply.

N Engl J Med August 1, 2021 DOI: 10.1056/nejmc2108082 via PubMed

Summary

AI-generated from the abstract

Psilocybin shows promise as a treatment for depression, though the evidence base remains limited and requires further rigorous study. The authors discuss the potential of psilocybin-assisted therapy to address mood disorders, emphasizing the need for more research to establish efficacy and safety. They highlight that while preliminary findings are encouraging, the field must proceed cautiously, with attention to methodological rigor and ethical considerations. The reply underscores the importance of continued investigation into psychedelic compounds as novel treatment options for mental health conditions.

Study at a glance

Characteristics Reply Peer reviewed
Topics Psilocybin
Keywords Psychedelics Depression treatment Therapy Mood disorders
Citations 14
Key finding Psilocybin shows potential as a treatment for depression, but more rigorous research is needed to confirm its efficacy and safety.

Abstract

Psilocybin for Depression. Reply.

Explore topics

Comments

No comments yet.

Log in to comment